BioSpace News Archive

Press Releases

Ultragenyx Receives Breakthrough Therapy Designation for Setrusumab (UX143) in Osteogenesis Imperfecta

October 7, 2024
·
6 min read
Press Releases

Sofwave Obtains U.S. Patent for Fat Tissue Reduction Technology

October 7, 2024
·
1 min read
Drug Development

Halia Therapeutics Announces First Healthy Volunteer Dosed with HT-4253, a Novel Oral LRRK2 Inhibitor Targeting Neuroinflammation in Alzheimer’s Disease

October 7, 2024
·
3 min read
News

Cognito Therapeutics to Present New Data for Spectris™ in Alzheimer’s Disease at CTAD 2024

October 7, 2024
·
3 min read
News

Reprieve Cardiovascular Completes Enrollment in Randomized Pilot Trial Evaluating First-of-its-Kind Personalized Fluid Management System for Acute Decompensated Heart Failure

October 7, 2024
·
4 min read
FDA

FDA Approves Use of Up To Three Tubes of Biofrontera Inc.’s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One Treatment

October 7, 2024
·
5 min read
Drug Development

New Considerations for Accelerating Combination Therapy Trials to be Showcased at 2024 Clinical Trials on Alzheimer’s Disease Conference

October 7, 2024
·
4 min read
Press Releases

Quantum BioPharma Ltd. Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and Parts of Central and South America

October 7, 2024
·
7 min read
Press Releases

U.S. IVD And LDT For Autoimmune Diseases Market Size to Hit USD 5.18 Billion by 2033

October 7, 2024
·
1 min read
Press Releases

Cellipont Bioservices Announces Darren Head As Chief Executive Officer & Minority Growth Equity Investment From HealthQuest Capital

October 7, 2024
·
4 min read